Medicines information

Information for patients about their medicines

Online information about medicines for mental health conditons (available for patients and staff)

The choice and medication website offers all patients access to online information about mental health conditions and the drugs used to treat them.

Information can be accessed by either searching the condition of a specific drug or drugs.

There are printable leaflets including easy read leaflets for patients with learning difficulties and printable leaflets in different languages 


People have the right to be involved in discussions and make informed decisions about their care and this includes medicines that are prescribed.

However, the large number of medicines available means that there are some benefits in having reviews of how and when they should be used within each Trust and producing a local formulary. This is usually presented as a list of medicines, some of which may be given preference, based on a number of factors such as the evidence of which work best for a given condition, side effects, interactions with other medicines, ease of use and cost. The decision making on which medicines are included is made by a multidisciplinary team.

Due to the large geographical area and variation of clinical services NELFT has a number of formularies; 

Several formularies are in use across NELFT. The table below is to help staff locate the correct formulary (as well as hospital only drug lists, shared care guidelines and prescribing guidances depending on where staff are working within the Trust.


NELFT Psychotropic Drug Formulary MHS November 2018 [pdf] 3MB

Antibiotic Formulary

Blood Glucose Formulary

Nutritional Supplements formulary

Palliative Care Formularies
Physiotherapy Formulary
Wound Care Formularies
Emollient Forumularies

Acute Trust Formulary

(for antibiotics formulary do not use this tab, use the Antibiotics tab above which has the most recent version)

Respiratory Formularies

The benefits of local formularies may include:

improving patient outcomes by optimising the use of medicines
supporting the inclusion of patient factors in decisions about medicines
improving local care pathways
improving collaboration between health professionals and commissioners
improving quality by reducing inappropriate variations in clinical care
improving quality through access to cost effective medicines
supporting the supply of medicines across a local health economy
supporting financial management and expenditure on medicines across health communities
supporting prescribers to follow guidance published by professional regulatory bodies in relation to medicines and prescribing.

Acute Trust Formulary & Hospital only drug lists

NELFT wide Essex boroughs 
(Basildon, Brentwood, Thurrock)
London boroughs 
(Barking & Dagenham, Redbridge, Havering)

London borough 
(Waltham Forest)

Acute Trust Formulary &
Hospital only drug lists
        BTUH hospital only          BHR Hospital only Barts Hospital only


NELFT shared care guidelines

  1. ADHD guidelines (for children and adolescents) [pdf] 962KB

  2. Adult ADHD guidelines [pdf] 251KB

  3. Lithium

  4. Melatonin - Barking Havering & Redbridge CCG, GPs and NELFT [pdf] 280KB

    Melatonin - Waltham Forest CCG, GPs and NELFT [pdf] 175KB

  5. Alzheimers Shared Care Protocol [pdf] 62KB ​​​​​​

Medicine Policy

Medicine Policy

NICE Technology Appraisals

When a new medicine is launched, NICE ( the National Institute for Health and Care Excellence) will review the medication to decide whether it should be made available on the NHS. These reviews are called technology appraisals.

The NHS Constitution for England, produced by the Department of Health, provides patients with the right that medicines that have been considered by NICE through the technology appraisal process and given a positive assessment should be made available, where appropriate, and therefore be included in the local formulary.

The Constitution also provides a right for patients to have decisions about medicines that have not yet been considered by, or have not received a positive recommendation for use in the NHS through, a NICE technology appraisal process to be made by the local NHS using a robust assessment of the best available evidence.

Further information on NICE guidance and technology appraisals can be found here